Follow the 세니젠 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 세니젠 has recorded 28 insider filings. Market capitalisation: €27.5bn. The latest transaction was disclosed on 10 July 2026 (Purchase). Among the most active insiders: 박정웅. Every trade is free.
26
Insider Decl.
n/a
Thresholds
n/a
9 ops.
Buy Volume
n/a
10 ops.
Sell Volume
Fundamental score
Ranked 28,193 of 29,063 companies
12.3
score / 100
Value
11
Quality
13
FCF yld-16%
Earn yld-21%
EV/EBITDA·
ROE-39%
Gross mgn20%
Net mgn-38%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
